Benzinga | May 6, 2021 05:39PM EDT

Checkpoint Therapeutics Q1 EPS $(0.09) Down From $(0.06) YoY, Sales $68.00K Down From $972.00K YoY

Checkpoint Therapeutics (NASDAQ:CKPT) reported quarterly losses of $(0.09) per share. This is a 50 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $68.00 thousand in sales this quarter. This is a 93.00 percent decrease over sales of $972.00 thousand the same period last year.